Lubdub Technologies Pty Ltd

Based in Australia, Lubdub Technologies Pty Ltd, operates as a provider of cardiac health monitoring and heart screening solutions. Based in Perth, Australia and founded in 2023, Lubdub Technologies Pty Ltd offers advanced cardiac health monitoring solutions. In September 2026, Lubdub Technologies Pty Ltd raised USD 6 mn in Seed funding from unspecified investors. The company will use the funding to advance development of its home-based cardiac diagnostic platform and progress toward clinical trial stages.

Lubdub Technologies specializes in advanced cardiac health monitoring solutions, focusing on the integration of three critical heart function tests: electrocardiograms, cardiac biomarkers, and echocardiograms. Their core offering, encapsulated in the concept of "heart health in a box," provides a versatile platform that enables comprehensive and personalized cardiac diagnostics at the point of need. This technology facilitates the instantaneous acquisition and indexing of heart health information through advanced data analytics, allowing specialists to review results remotely for screening and diagnosis. The company's solutions target healthcare providers and institutions, aiming to improve access to vital cardiac assessments for patients across diverse geographical markets, including Australia, North America, and select regions in Europe.

Lubdub Technologies generates revenue through its innovative health technology offerings, primarily by engaging directly with healthcare providers and institutions that adopt their diagnostic tools. The company operates on a business-to-business (B2B) model, providing subscription or purchase options for its integrated cardiac health monitoring systems. These transactions primarily involve healthcare facilities purchasing the "heart health in a box" product, potentially leading to long-term partnerships for continuous service support and data analytics. Pricing structures are designed to accommodate various client needs, ensuring accessibility for both large hospitals and smaller clinics.

The scalability of their offerings aligns with the increasing demand for personalized, on-demand health diagnostics, facilitating a robust client base across the healthcare spectrum. The company plans to advance the development of its home-based cardiac diagnostic platform and progress toward clinical trial stages.